Holen Sie sich die Stockscreener-App
1.34
2.90%
-0.04
Handel nachbörslich:
1.21
-0.13
-9.70%
Schlusskurs vom Vortag:
$1.38
Offen:
$1.39
24-Stunden-Volumen:
19,617
Relative Volume:
0.04
Marktkapitalisierung:
$6.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-21.13M
KGV:
-0.2797
EPS:
-4.79
Netto-Cashflow:
$-16.95M
1W Leistung:
-12.53%
1M Leistung:
-30.93%
6M Leistung:
+119.67%
1J Leistung:
+130.28%
1-Tages-Spanne:
$1.30
$1.39
1-Wochen-Bereich:
$1.30
$1.56
52-Wochen-Spanne:
$0.4748
$3.09
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Firmenname
Matinas Biopharma Holdings Inc
Sektor
Branche
Telefon
908-443-1860
Adresse
1545 Route 206 South, Suite 302, Bedminster, NJ
Vergleichen Sie MTNB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.34 | 7.66M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-11 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-01-27 | Eingeleitet | Piper Sandler | Overweight |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2020-01-09 | Eingeleitet | Aegis Capital | Buy |
| 2019-06-26 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Matinas Biopharma Holdings Inc Aktie (MTNB) Neueste Nachrichten
Can Matinas BioPharma Holdings Inc. hit a new high this monthPortfolio Update Summary & AI Enhanced Trading Signals - newser.com
How Matinas BioPharma Holdings Inc. (6LJ0) stock reacts to new regulationsEarnings Risk Report & AI Forecast Swing Trade Picks - newser.com
How Matinas BioPharma Holdings Inc. stock compares to market leadersPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
How moving averages guide Matinas BioPharma Holdings Inc. trading2025 Historical Comparison & AI Forecasted Entry/Exit Points - newser.com
Why Matinas Biopharma Holdings Inc. stock attracts wealthy investors2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 2025 - newser.com
Is Matinas Biopharma Holdings Inc. stock supported by free cash flowGlobal Markets & Accurate Trade Setup Notifications - newser.com
How Matinas Biopharma Holdings Inc. stock reacts to stronger dollarEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
How rising interest rates impact Matinas BioPharma Holdings Inc. stock2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Can Matinas BioPharma Holdings Inc. stock maintain operating marginsJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Technical analysis overview for Matinas BioPharma Holdings Inc. stock2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
Is Matinas BioPharma Holdings Inc. stock bottoming outPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com
Will Matinas BioPharma Holdings Inc. (6LJ0) stock outperform value peersDollar Strength & Safe Investment Capital Preservation Plans - newser.com
What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - newser.com
Matinas BioPharma Holdings Inc 6LJ0 Stock Analysis and ForecastMarket Breadth Indicators & High-Risk, High-Reward? We Find the Winners - earlytimes.in
Sector ETF performance correlation with Matinas BioPharma Holdings Inc.Earnings Risk Summary & Fast Entry High Yield Tips - newser.com
Is Matinas Biopharma Holdings Inc. stock prepared for digital transition2025 Biggest Moves & AI Powered Buy and Sell Recommendations - newser.com
Will Matinas BioPharma Holdings Inc. stock attract ESG investorsSell Signal & Long-Term Safe Investment Ideas - newser.com
Can Matinas Biopharma Holdings Inc. stock sustain revenue momentumJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Can Matinas Biopharma Holdings Inc. stock resist broad market declinesMarket Movement Recap & Daily Profit Focused Stock Screening - newser.com
What technical charts say about Matinas BioPharma Holdings Inc. stockAnalyst Downgrade & Long-Term Safe Investment Plans - newser.com
Detecting support and resistance levels for Matinas BioPharma Holdings Inc.July 2025 Selloffs & Risk Managed Investment Strategies - newser.com
Key metrics from Matinas BioPharma Holdings Inc.’s quarterly dataMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
What makes Simon Property Group, Inc. stock price move sharply - newser.com
What makes Matinas Biopharma Holdings Inc. stock appealing to growth investorsAnalyst Downgrade & High Conviction Buy Zone Alerts - newser.com
Total debt per share of Matinas BioPharma Holdings, Inc. – MUN:6LJ0 - TradingView
Finanzdaten der Matinas Biopharma Holdings Inc-Aktie (MTNB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):